| Section | Rationale | Description |
|---|---|---|
| ED-1 | ED-1 is being retired as of 1/1/2026. ED-1 will be removed from ORYX. This measure will be maintained through 2026 discharges. | Header Add: This measure is retired as of January 1, 2026. |
| ED-2 | ED-2 is being retired as of 1/1/2026. ED-2 will be removed from ORYX. This measure will be maintained through 2026 discharges. | Header Add: This measure is retired as of January 1, 2026. |
| IMM-2 | IMM-2 is being retired as of 1/1/2026. IMM-2 will be removed from ORYX. This measure will be maintained through 2026 discharges. | Header Add: Removed from ORYX. Measure will be maintained through 2026 discharges. |
| PC | A note was added to denote that PC-01, PC-02, and PC-05 are being retired as of January 1, 2026 from ORYX. | Initial Patient Population Add: Note: PC-01, PC-02, and PC-05 are being retired as of January 1, 2026 from ORYX, still in use for Certification. |
| PC-01 | This measure is removed from ORYX but still in use in certification. | Header Add: **Effective January 1, 2026, this measure is removed from ORYX, still in use in Certification** |
| PC-02 | This measure is removed from ORYX but still in use in Certification. | Header Add: **Effective January 1, 2026, this measure is removed from ORYX, still in use in Certification** |
| PC-05 | This measure is removed from ORYX but still in use in Certification. | Header Add: **Effective January 1, 2026, this measure is removed from ORYX, still in use in Certification** |
| SUB-2 | SUB-2 is being retired as of 1/1/2026. SUB-2 will be removed from ORYX. This measure will be maintained through 2026 discharges. | Header Add: Removed from ORYX. Measure will be maintained through 2026 discharges. |
| SUB-3 | SUB-3 is being retired as of 1/1/2026. SUB-3 will be removed from ORYX. This measure will be maintained through 2026 discharges. | Header Add: Removed from ORYX. Measure will be maintained through 2026 discharges. |
| TOB-3 | TOB-3 is being retired as of 1/1/2026. TOB-3 will be removed from ORYX. This measure will be maintained through 2026 discharges. | Header Add: Removed from ORYX. Measure will be maintained through 2026 discharges. |
| Section | Rationale | Description |
|---|---|---|
| No Data Element release notes for the TJC2026A1 release. | ||
| Section | Rationale | Description |
|---|---|---|
| Global Initial Patient Population | The ED, IMM, SUB, and TOB measure sets are being retired as of January 1, 2026. | Add: Note: The ED, IMM, SUB, and TOB measure sets are being retired as of January 1, 2026. These measure sets are removed from ORYX. Measures will be maintained through 2026 discharges. |
| Table of Contents | Retired measures are denoted with the following note: Removed from ORYX. Measure will be maintained through 2026 discharges. | Add: ED-1, ED-2, IMM-2, SUB-2, SUB-3, TOB-3 are denoted as (Removed from ORYX. Measure will be maintained through 2026 discharges). |
| Rationale | Description |
|---|---|
| The Addendum reflects modifications to measures based off changes from the 2026 ORYX Requirements. Please see the Table of Contents for specific modifications to measures. | The Addendum reflects modifications to measures based off changes from the 2026 ORYX Requirements. Please see the Table of Contents for specific modifications to measures. |
CPT® only copyright 2025 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.
You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.
Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.
U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.
Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.
This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.
Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.